PKO Investment Management Joint-Stock’s Boston Scientific BSX Stock Holding History

PKO Investment Management Joint-Stock’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$982K	Buy	23,000 +1,500	+7%	+$81.5K	0.07%	178
2026 Q1	$1.35M	Sell	21,500 -1,000	-4%	-$80K	0.11%	139
2025 Q4	$2.15M	Buy	22,500 +500	+2%	+$49K	0.17%	106
2025 Q3	$2.15M	Buy	22,000 +9,000	+69%	+$932K	0.18%	103
2025 Q2	$1.4M	Hold	13,000	–	–	0.15%	109
2025 Q1	$1.31M	Buy	13,000 +3,000	+30%	+$302K	0.15%	105
2024 Q4	$893K	Buy	10,000 +5,000	+100%	+$440K	0.11%	114
2024 Q3	$419K	Hold	5,000	–	–	0.05%	143
2024 Q2	$385K	Sell	5,000 -3,000	-38%	-$220K	0.05%	153
2024 Q1	$551K	Sell	8,000 -4,000	-33%	-$257K	0.07%	143
2023 Q4	$694K	Buy	12,000 +4,000	+50%	+$214K	0.09%	121
2023 Q3	$422K	Buy	+8,000	New	+$420K	0.06%	126
2023 Q2	–	Sell	-10,000	Closed	-$500K	–	145
2023 Q1	$500K	Sell	10,000 -7,000	-41%	-$330K	0.07%	127
2022 Q4	$787K	Hold	17,000	–	–	0.11%	109
2022 Q3	$658K	Hold	17,000	–	–	0.11%	105
2022 Q2	$634K	Buy	+17,000	New	+$692K	0.09%	105

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Banque Transatlantique Paris, France $4.66B AUM 33.26% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

PKO Investment Management Joint-Stock's BSX Position: Q2 2026 in Review

PKO Investment Management Joint-Stock increased its Boston Scientific (BSX) stake by 7% in Q2 2026, buying an estimated $81.5K and bringing the position to 23,000 shares worth $982K. The position accounts for 0.07% of the portfolio, ranked #178.

PKO Investment Management Joint-Stock first reported a position in BSX in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.15M in Q3 2025. 489 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

PKO Investment Management Joint-Stock held 23,000 shares of Boston Scientific worth $982K as of Q2 2026.
PKO Investment Management Joint-Stock bought 1,500 Boston Scientific shares in Q2 2026, an estimated $81.5K.
Boston Scientific made up 0.07% of PKO Investment Management Joint-Stock's portfolio in Q2 2026, its #178 holding.
PKO Investment Management Joint-Stock first reported a position in Boston Scientific in Q2 2022 and has held it in 16 quarters since.
PKO Investment Management Joint-Stock's Boston Scientific position peaked at $2.15M in Q3 2025.
489 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on PKO Investment Management Joint-Stock's 13F filing for Q2 2026, filed 20 Jul 2026.